Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.05
AMSG's Cash to Debt is ranked lower than
83% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. AMSG: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
AMSG' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.13 Max: 1.51
Current: 0.05
0.05
1.51
Equity to Asset 0.31
AMSG's Equity to Asset is ranked lower than
68% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. AMSG: 0.31 )
Ranked among companies with meaningful Equity to Asset only.
AMSG' s 10-Year Equity to Asset Range
Min: 0.3  Med: 0.54 Max: 0.8
Current: 0.31
0.3
0.8
F-Score: 5
Z-Score: 1.26
M-Score: -2.09
WACC vs ROIC
8.89%
13.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 22.12
AMSG's Operating margin (%) is ranked higher than
90% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 7.02 vs. AMSG: 22.12 )
Ranked among companies with meaningful Operating margin (%) only.
AMSG' s 10-Year Operating margin (%) Range
Min: 24.31  Med: 33.09 Max: 63.3
Current: 22.12
24.31
63.3
Net-margin (%) 2.98
AMSG's Net-margin (%) is ranked lower than
51% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. AMSG: 2.98 )
Ranked among companies with meaningful Net-margin (%) only.
AMSG' s 10-Year Net-margin (%) Range
Min: 0.17  Med: 7.28 Max: 12
Current: 2.98
0.17
12
ROE (%) 3.83
AMSG's ROE (%) is ranked lower than
67% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 8.74 vs. AMSG: 3.83 )
Ranked among companies with meaningful ROE (%) only.
AMSG' s 10-Year ROE (%) Range
Min: 1.6  Med: 10.80 Max: 16.3
Current: 3.83
1.6
16.3
ROA (%) 1.37
AMSG's ROA (%) is ranked lower than
62% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. AMSG: 1.37 )
Ranked among companies with meaningful ROA (%) only.
AMSG' s 10-Year ROA (%) Range
Min: 0.92  Med: 5.58 Max: 10.16
Current: 1.37
0.92
10.16
ROC (Joel Greenblatt) (%) 145.58
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 15.85 vs. AMSG: 145.58 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMSG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 42.63  Med: 90.97 Max: 144.28
Current: 145.58
42.63
144.28
Revenue Growth (3Y)(%) 18.00
AMSG's Revenue Growth (3Y)(%) is ranked higher than
86% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. AMSG: 18.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMSG' s 10-Year Revenue Growth (3Y)(%) Range
Min: 9.9  Med: 15.20 Max: 19.4
Current: 18
9.9
19.4
EBITDA Growth (3Y)(%) 10.50
AMSG's EBITDA Growth (3Y)(%) is ranked higher than
61% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. AMSG: 10.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMSG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9  Med: 12.20 Max: 40.6
Current: 10.5
-9
40.6
EPS Growth (3Y)(%) -7.40
AMSG's EPS Growth (3Y)(%) is ranked lower than
77% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 9.90 vs. AMSG: -7.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AMSG' s 10-Year EPS Growth (3Y)(%) Range
Min: -7.4  Med: 10.90 Max: 135.1
Current: -7.4
-7.4
135.1
» AMSG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

AMSG Guru Trades in Q2 2014

Louis Moore Bacon 110,000 sh (New)
Paul Tudor Jones 131,573 sh (New)
Joel Greenblatt 149,988 sh (+21.57%)
Jim Simons 245,469 sh (+3.15%)
» More
Q3 2014

AMSG Guru Trades in Q3 2014

Joel Greenblatt 586,771 sh (+291.21%)
Louis Moore Bacon Sold Out
Jim Simons 19,469 sh (-92.07%)
Paul Tudor Jones 7,700 sh (-94.15%)
» More
Q4 2014

AMSG Guru Trades in Q4 2014

Steven Cohen 215,800 sh (New)
Jim Simons 160,369 sh (+723.71%)
Paul Tudor Jones 11,500 sh (+49.35%)
Joel Greenblatt Sold Out
» More
Q1 2015

AMSG Guru Trades in Q1 2015

Joel Greenblatt 10,617 sh (New)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Jim Simons 146,569 sh (-8.61%)
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Amsurg Corp

SymbolPriceYieldDescription
AMSGP136.513.84

Ratios

vs
industry
vs
history
P/E(ttm) 55.41
AMSG's P/E(ttm) is ranked lower than
79% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. AMSG: 55.41 )
Ranked among companies with meaningful P/E(ttm) only.
AMSG' s 10-Year P/E(ttm) Range
Min: 9.07  Med: 17.61 Max: 57.54
Current: 55.41
9.07
57.54
Forward P/E 17.64
AMSG's Forward P/E is ranked higher than
62% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 19.31 vs. AMSG: 17.64 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 55.10
AMSG's PE(NRI) is ranked lower than
80% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 27.80 vs. AMSG: 55.10 )
Ranked among companies with meaningful PE(NRI) only.
AMSG' s 10-Year PE(NRI) Range
Min: 8.55  Med: 18.02 Max: 56.2
Current: 55.1
8.55
56.2
P/B 2.16
AMSG's P/B is ranked higher than
60% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 2.74 vs. AMSG: 2.16 )
Ranked among companies with meaningful P/B only.
AMSG' s 10-Year P/B Range
Min: 0.93  Med: 1.75 Max: 3.4
Current: 2.16
0.93
3.4
P/S 1.57
AMSG's P/S is ranked lower than
52% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. AMSG: 1.57 )
Ranked among companies with meaningful P/S only.
AMSG' s 10-Year P/S Range
Min: 0.7  Med: 1.35 Max: 2.69
Current: 1.57
0.7
2.69
PFCF 7.64
AMSG's PFCF is ranked higher than
90% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 21.20 vs. AMSG: 7.64 )
Ranked among companies with meaningful PFCF only.
AMSG' s 10-Year PFCF Range
Min: 1.92  Med: 4.84 Max: 56.85
Current: 7.64
1.92
56.85
POCF 6.80
AMSG's POCF is ranked higher than
86% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 15.30 vs. AMSG: 6.80 )
Ranked among companies with meaningful POCF only.
AMSG' s 10-Year POCF Range
Min: 1.75  Med: 4.41 Max: 16.23
Current: 6.8
1.75
16.23
EV-to-EBIT 14.24
AMSG's EV-to-EBIT is ranked higher than
72% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 19.98 vs. AMSG: 14.24 )
Ranked among companies with meaningful EV-to-EBIT only.
AMSG' s 10-Year EV-to-EBIT Range
Min: 3  Med: 5.50 Max: 14.6
Current: 14.24
3
14.6
PEG 6.05
AMSG's PEG is ranked lower than
79% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 3.23 vs. AMSG: 6.05 )
Ranked among companies with meaningful PEG only.
AMSG' s 10-Year PEG Range
Min: 0.3  Med: 1.14 Max: 87.64
Current: 6.05
0.3
87.64
Shiller P/E 37.50
AMSG's Shiller P/E is ranked lower than
68% of the 81 Companies
in the Global Medical Care industry.

( Industry Median: 31.33 vs. AMSG: 37.50 )
Ranked among companies with meaningful Shiller P/E only.
AMSG' s 10-Year Shiller P/E Range
Min: 9.92  Med: 20.23 Max: 39.39
Current: 37.5
9.92
39.39
Current Ratio 1.73
AMSG's Current Ratio is ranked higher than
66% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. AMSG: 1.73 )
Ranked among companies with meaningful Current Ratio only.
AMSG' s 10-Year Current Ratio Range
Min: 1.73  Med: 3.30 Max: 4.94
Current: 1.73
1.73
4.94
Quick Ratio 1.66
AMSG's Quick Ratio is ranked higher than
70% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. AMSG: 1.66 )
Ranked among companies with meaningful Quick Ratio only.
AMSG' s 10-Year Quick Ratio Range
Min: 1.66  Med: 3.10 Max: 4.62
Current: 1.66
1.66
4.62
Days Inventory 41.79
AMSG's Days Inventory is ranked lower than
75% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 17.78 vs. AMSG: 41.79 )
Ranked among companies with meaningful Days Inventory only.
AMSG' s 10-Year Days Inventory Range
Min: 11  Med: 14.19 Max: 46.57
Current: 41.79
11
46.57
Days Sales Outstanding 46.05
AMSG's Days Sales Outstanding is ranked higher than
52% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. AMSG: 46.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMSG' s 10-Year Days Sales Outstanding Range
Min: 35.64  Med: 43.77 Max: 62.96
Current: 46.05
35.64
62.96

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.62
AMSG's Price/Projected FCF is ranked higher than
92% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. AMSG: 0.62 )
Ranked among companies with meaningful Price/Projected FCF only.
AMSG' s 10-Year Price/Projected FCF Range
Min: 0.24  Med: 0.52 Max: 2.99
Current: 0.62
0.24
2.99
Price/DCF (Earnings Based) 5.24
AMSG's Price/DCF (Earnings Based) is ranked lower than
100% of the 23 Companies
in the Global Medical Care industry.

( Industry Median: 1.43 vs. AMSG: 5.24 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.17
AMSG's Price/Median PS Value is ranked lower than
51% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. AMSG: 1.17 )
Ranked among companies with meaningful Price/Median PS Value only.
AMSG' s 10-Year Price/Median PS Value Range
Min: 0.5  Med: 1.03 Max: 2.09
Current: 1.17
0.5
2.09
Price/Peter Lynch Fair Value 5.30
AMSG's Price/Peter Lynch Fair Value is ranked lower than
90% of the 50 Companies
in the Global Medical Care industry.

( Industry Median: 2.36 vs. AMSG: 5.30 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
AMSG' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4  Med: 1.12 Max: 4.71
Current: 5.3
0.4
4.71
Earnings Yield (Greenblatt) (%) 6.97
AMSG's Earnings Yield (Greenblatt) (%) is ranked higher than
77% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. AMSG: 6.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMSG' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.8  Med: 18.20 Max: 33
Current: 6.97
6.8
33
Forward Rate of Return (Yacktman) (%) 21.92
AMSG's Forward Rate of Return (Yacktman) (%) is ranked higher than
82% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.96 vs. AMSG: 21.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AMSG' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 0.2  Med: 26.50 Max: 61
Current: 21.92
0.2
61

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AJH.Germany,
AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.
» More Articles for AMSG

Headlines

Articles On GuruFocus.com
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
predictable Sep 28 2011 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
View on AMSG Apr 30 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
AMSURG CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 21 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Second Quarter 2015 Results Jul 07 2015
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Second Quarter 2015 Results Jul 07 2015
AmSurg Arm Buys Anesthesia Provider, Expands in Florida - Analyst Blog Jul 03 2015
AmSurg’s Physician Services Division, Sheridan, Announces Acquisition of Coastal Anesthesiology... Jul 02 2015
AmSurg’s Physician Services Division, Sheridan, Announces Acquisition of Coastal Anesthesiology... Jul 02 2015
Coverage initiated on AmSurg by Goldman Jun 05 2015
AmSurg Corp. to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Jun 03 2015
AmSurg Corp. to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Jun 03 2015
AmSurg Corp. to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
AmSurg Corp. to Present at the Jefferies 2015 Global Healthcare Conference May 26 2015
AMSURG CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... May 22 2015
AmSurg Declares Quarterly Preferred Stock Dividend May 20 2015
AmSurg Declares Quarterly Preferred Stock Dividend May 20 2015
AMSURG CORP Financials May 15 2015
Can AmSurg Corp. (AMSG) Stock Continue to Grow Earnings? - Tale of the Tape May 15 2015
10-Q for AmSurg Corp. May 08 2015
AmSurg Beats Q1 Earnings on Solid Revenues; Guides Up - Analyst Blog May 07 2015
AMSURG CORP Files SEC form 8-K/A, Results of Operations and Financial Condition May 06 2015
AmSurg Corp Earnings Call scheduled for 9:00 am ET today May 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK